We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+26.41%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$8.88B
AUM Growth
+$2.09B
(+31%)
Cap. Flow
+$564M
Cap. Flow
% of AUM
6.36%
Top 10 Holdings %
Top 10 Hldgs %
40.05%
Holding
908
New
100
Increased
273
Reduced
455
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$76.1M |
| 2 |
Enterprise Products Partners
EPD
|
+$64.2M |
| 3 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$44.1M |
| 4 |
MPLX
MPLX
|
+$22M |
| 5 |
Plains All American Pipeline
PAA
|
+$21.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$23.3M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$21.9M |
| 3 |
Eastman Chemical
EMN
|
+$21.3M |
| 4 |
Duke Energy
DUK
|
+$20.8M |
| 5 |
Broadcom
AVGO
|
+$20.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 48.15% |
| 2 | Financials | 11.06% |
| 3 | Technology | 6.82% |
| 4 | Healthcare | 5.49% |
| 5 | Industrials | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
376
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.13M | 0.01% |
7,255
-690
| -9% | -$88.7K |
|
|
VXRT
377
DELISTED
Vaxart
VXRT
| $1.13M | 0.01% |
+197,384
| New | +$1.26M |
|
|
ISEE
378
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.12M | 0.01% |
161,774
+47,635
| +42% | +$305K |
|
|
FABC
379
Fabric.AI Inc
FABC
$16.8M
| $1.09M | 0.01% |
+1,400
| New | +$852K |
|
380
Monolithic Power Systems
MPWR
$65.8B
| $1.09M | 0.01% |
2,970
-288
| -9% | -$92.3K |
|
381
Dollar General
DG
$27.2B
| $1.08M | 0.01% |
5,157
-247
| -5% | -$52.8K |
|
382
Zebra Technologies
ZBRA
$12.6B
| $1.08M | 0.01% |
2,800
-236
| -8% | -$79.4K |
|
383
Alphabet (Google) Class A
GOOGL
$3.99T
| $1.06M | 0.01% |
12,140
-10,820
| -47% | -$910K |
|
384
AnaptysBio
ANAB
$1.59B
| $1.06M | 0.01% |
49,352
+14,538
| +42% | +$353K |
|
385
Harmony Gold Mining
HMY
$9.92B
| $1.02M | 0.01% |
219,118
-686,655
| -76% | -$3.38M |
|
386
Brookfield Infrastructure
BIPC
$5.03B
| $1.02M | 0.01% |
21,132
| – | – |
|
387
AngloGold Ashanti
AU
$40.7B
| $1.01M | 0.01% |
44,739
-215,335
| -83% | -$5.17M |
|
388
CubeSmart
CUBE
$9.57B
| $1M | 0.01% |
29,897
+14,007
| +88% | +$469K |
|
389
Elevance Health
ELV
$82.1B
| $1M | 0.01% |
3,122
-711
| -19% | -$218K |
|
390
Kiniksa Pharmaceuticals
KNSA
$4.89B
| $1M | 0.01% |
+56,627
| New | +$995K |
|
391
Alaunos Therapeutics
TCRT
$4.71M
| $975K | 0.01% |
+2,581
| New | +$1.03M |
|
392
Xenon Pharmaceuticals
XENE
$6.36B
| $973K | 0.01% |
63,254
+18,630
| +42% | +$218K |
|
393
Gold Fields
GFI
$29.4B
| $970K | 0.01% |
104,660
-328,488
| -76% | -$3.47M |
|
394
Fulton Financial
FULT
$4.67B
| $963K | 0.01% |
75,683
-3,567
| -5% | -$42.4K |
|
395
Entegris
ENTG
$19.2B
| $938K | 0.01% |
9,761
-726
| -7% | -$63.4K |
|
|
TECX
396
Tectonic Therapeutic
TECX
$578M
| $918K | 0.01% |
5,489
+1,617
| +42% | +$287K |
|
|
SYRS
397
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $897K | 0.01% |
8,271
+2,435
| +42% | +$222K |
|
398
Geron
GERN
$949M
| $892K | 0.01% |
+561,172
| New | +$1.02M |
|
|
CPRX
399
DELISTED
Catalyst Pharmaceutical
CPRX
| $885K | 0.01% |
265,002
+52,699
| +25% | +$177K |
|
|
ETNB
400
DELISTED
89bio
ETNB
| $876K | 0.01% |
+35,931
| New | +$919K |
|
Similar funds
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, ALPS Advisors held 908 positions worth $8.88B, up 31% from $6.79B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
ALPS Advisors deployed $564M of net new capital in Q4 2020, opening 100 new positions and adding to 273 existing holdings. Its largest new stake was Genuine Parts: 212,300 shares worth $21.3M.
By sector, the portfolio is most concentrated in Energy at 48% of assets, up from 46% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was WestRock Company, an estimated $23.3M trimmed.
- ALPS Advisors's largest Q4 2020 buy was Genuine Parts: 212,300 shares worth $21.3M.
- ALPS Advisors added most to Energy Transfer Partners in Q4 2020, an estimated $76.1M increase.
- ALPS Advisors's biggest Q4 2020 reduction was WestRock Company, cutting an estimated $23.3M.
- ALPS Advisors fully exited Duke Energy in Q4 2020, selling an estimated $20.8M.
- ALPS Advisors's ten largest holdings make up 40% of its $8.88B portfolio in Q4 2020.
- ALPS Advisors opened 100 new positions and closed 75 in Q4 2020.
- ALPS Advisors's portfolio value rose 31% quarter-over-quarter to $8.88B.
Based on ALPS Advisors's 13F filing for Q4 2020, filed 3 Feb 2021.